Global Gastroesophageal Reflux Disease Therapeutics Market Report 2024

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024 – By Type (Branded, Generic), By Drug Class (Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class), By Distribution Channel (Hospital Pharmacy, Drug Stores, General Stores, Supermarkets), By Application (Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis) – Market Size, Trends, And Global Forecast 2024-2033

Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Gastroesophageal Reflux Disease Therapeutics Market Definition And Segments

Gastroesophageal reflux disease (GERD) therapeutics is a medication for chronic medical illness characterized by the upward movement of stomach contents into the esophagus that causes heartburn and regurgitation. The therapeutics are used to neutralize and reduce the production of stomach acid to maintain optimal pH in the gut and prevent the passage of fluids back into the stomach that cause acid reflux.

The main gastroesophageal reflux disease therapeutics are branded and generic. Branded refers to any medical substance that may only be supplied according to a prescription order from a physician or other authorized prescriber under state or federal rules and these drugs are used to treatment of gastroesophageal reflux disease to eliminate symptoms and allow esophageal healing. The various drug classes are antacids, proton pump inhibitors, histamine blockers, pro-kinetic agents, and others that are distributed using different channels such as hospital pharmacies, drug stores, general stores, and supermarkets. These are applied in Crohn’s disease, gastroesophageal reflux disease (GERD), and ulcerative colitis.

The gastroesophageal reflux disease therapeutics market covered in this report is segmented –

1) By Type: Branded, Generic

2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class

3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets

4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis

The gastroesophageal reflux disease therapeutics market size has grown steadily in recent years. It will grow from $5.78 billion in 2023 to $6 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to changing lifestyles and dietary habits, aging population, increased awareness and diagnosis, prevailing stressful lifestyles, rise in obesity rates.

The gastroesophageal reflux disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rise in demand for novel therapies, growing geriatric population, personalized medicine approaches, focus on non-pharmacological interventions, emergence of biologics and innovative therapies. Major trends in the forecast period include alternative therapies and mind-body practices, expanded research into gut health, advent of patient-centric care models, targeted marketing for gerd awareness, integration of digital health tools.

Surge In Gastroesophageal Reflux Disease Anticipated To Drive The Growth Of The Gastroesophageal Reflux Disease Therapeutics Market

The prevalence of gastroesophageal reflux disease is expected to propel the growth of the gastroesophageal reflux disease therapeutics market moving forward. Gastroesophageal reflux disease is a chronic condition characterized by the backflow of stomach acid into the esophagus, causing symptoms such as heartburn, regurgitation, and potential complications. The gastroesophageal reflux disease (GERD) therapeutics help in reducing and managing the symptoms of acid reflux by neutralizing the pH of the gut, controlling inflammation, and improving esophageal function. For instance, in September 2022, according to the article published by WebMed, a US-based online publisher of news and information about human health, more than 60 million American adults suffer heartburn at least once a month, and more than 15 million suffer daily. Furthermore, in July 2022, statistics shared by the National Library of Medicine, a US-based federal medical library, GERD is one of the most often diagnosed digestive illnesses in the United States, with a 20% prevalence, resulting in a significant economic burden in direct and indirect expenditures as well as a negative impact on quality of life. Therefore, the prevalence of gastroesophageal reflux disease is expected to drive the growth of the gastroesophageal reflux disease therapeutics market.

Self-Medication Trends Propel The Gastroesophageal Reflux Disease Therapeutics Market

The adoption of self-medication is significantly contributing to the growth of the gastroesophageal reflux disease therapeutics market going forward. Self-medication is the practice of using drugs or other substances to treat a medical condition without consulting a healthcare professional. Self-medication plays a significant role in identifying and avoiding trigger foods, managing stress, and quitting smoking, which can significantly improve GERD symptoms. For instance, in May 2022, according to a survey of 170 people by Lippincott Williams & Wilkins, a US-based provider of professional health information, around 57.7% reported practicing self-medication, and 34.7% felt a lack of need to visit a medical practitioner in 2022. Therefore, the adoption of remote working will drive the gastroesophageal reflux disease therapeutics market.

Major companies operating in the gastroesophageal reflux disease therapeutics market report are Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca PLC, Medtronic PLC, GlaxoSmithKline PLC, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, bioMerieux SA, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories Ltd., Bruker Corp, Amneal Pharmaceuticals LLC, CHEPLAPHARM Arzneimittel GmbH, Daewoong Pharmaceutical Co. Ltd., Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., EndoGastric Solutions, RaQualia Pharma Inc., TWi Pharmaceuticals Inc., Astellas Pharma Inc., SFJ Pharmaceuticals Group, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Addex Pharmacetuicals.

Innovative Medications To Reshape The Gastroesophageal Reflux Disease Therapeutics Market

Product innovations are the key trend gaining popularity in the gastroesophageal reflux disease therapeutics market. Major companies operating in the gastroesophageal reflux disease therapeutics market are focusing on innovative medications to sustain their position in the market. For instance, in March 2021, Xiromed LLC, a US-based integrated generic company, launched Omeprazole Delayed-Release Capsules (generic to Prilosec) to treat frequent heartburn in gastroesophageal reflux. Omeprazole is a proton pump inhibitor (PPI) medication designed to treat some stomach and esophageal issues (such as acid reflux and ulcers) by lowering the quantity of acid produced by the stomach that alleviating symptoms such as heartburn, trouble swallowing, and persistent cough. This drug helps cure acid damage to the stomach and esophagus, prevents ulcers, and may help prevent oesophageal cancer.

Advanced Diagnostic Solutions For Gastroesophageal Reflux Disease Therapeutics

Major companies operating in the gastroesophageal reflux disease therapeutics market are concentrating towards developing innovative systems such as wireless pH-capsule reflux testing systems. Wireless pH-capsule reflux testing systems are medical devices designed for the diagnosis and monitoring of gastroesophageal reflux disease (GERD) and related conditions. For instance, in April 2023, Laborie Medical Technologies Corp., a US-based medical testing equipment manufacturing company, announced the launch of alpHaONE system. It is a wireless pH-capsule reflux testing system that is specifically designed to diagnose gastroesophageal reflux disease (GERD). The system offers upto 96 hours of data monitoring, provides accurate and reliable data. alpHaONE presents a distinctive solution featuring an ergonomic and compact design, enlarged buttons that are easy to press, and a fail-safe capsule delivery system designed to safeguard the patients oesophagus.

Evonik And Phathom Pharmaceuticals Join Forces For Gerd Drug Manufacturing

In October 2022, Evonik Industries AG, a Germany-based specialty chemicals company, partnered with Phathom Pharmaceuticals. Through the agreement, Evonik aims to produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in USA and Germany. Phathom Pharmaceuticals is a US-based biopharmaceutical firm focused on innovative medicines for stomach acid-related disorders offering gastroesophageal reflux disease drugs.

North America was the largest region in the gastroesophageal reflux disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastroesophageal reflux disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastroesophageal reflux disease (GERD) therapeutics market consists of sales of amino-salicylates (5-ASA), corticosteroids, immunomodulators, antibiotics, biologics, and dopamine receptor antagonist. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The gastroesophageal reflux disease therapeutics market research report is one of a series of new reports from The Business Research Company that provides gastroesophageal reflux disease therapeutics market statistics, including gastroesophageal reflux disease therapeutics industry global market size, regional shares, competitors with a gastroesophageal reflux disease therapeutics market share, detailed gastroesophageal reflux disease therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the gastroesophageal reflux disease therapeutics industry. This gastroesophageal reflux disease therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gastroesophageal Reflux Disease Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $6 billion
Revenue Forecast In 2033 $7.33 billion
Growth Rate CAGR of 5.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Branded, Generic
2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets
4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson and Johnson; Novartis AG; Sanofi S.A.; AstraZeneca plc; Medtronic PLC; GlaxoSmithKline plc; Eisai Co. Ltd.; Takeda Pharmaceutical Company Limited; bioMerieux SA; Teva Pharmaceutical Industries; Dr. Reddy's Laboratories Ltd.; Bruker Corp; Amneal Pharmaceuticals LLC; CHEPLAPHARM Arzneimittel GmbH; Daewoong Pharmaceutical Co. Ltd; Ironwood Pharmaceuticals Inc.; Sebela Pharmaceuticals Inc.; Camber Pharmaceuticals Inc.; Sun Pharmaceutical Industries Ltd.; EndoGastric Solutions; RaQualia Pharma Inc; TWi Pharmaceuticals Inc.; Astellas Pharma Inc.; SFJ Pharmaceuticals Group; Boehringer Ingelheim International GmbH; Cadila Pharmaceuticals Limited; Addex Pharmacetuicals.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Gastroesophageal Reflux Disease Therapeutics Market Characteristics

    3. Gastroesophageal Reflux Disease Therapeutics Market Trends And Strategies

    4. Gastroesophageal Reflux Disease Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Gastroesophageal Reflux Disease Therapeutics Market Size and Growth

    5.1. Global Gastroesophageal Reflux Disease Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Gastroesophageal Reflux Disease Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Gastroesophageal Reflux Disease Therapeutics Market Segmentation

    6.1. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Branded

    Generic

    6.2. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Antacids

    Proton Pump Inhibitors

    Histamine Blockers

    Pro-Kinetic Agents

    Other Drugs Class

    6.3. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacy

    Drug Stores

    General Stores

    Supermarkets

    6.4. Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Crohn’s Disease

    Gastroesophageal Reflux Disease (GERD)

    Ulcerative Colitis

    7. Gastroesophageal Reflux Disease Therapeutics Market Regional And Country Analysis

    7.1. Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market

    8.1. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Gastroesophageal Reflux Disease Therapeutics Market

    9.1. China Gastroesophageal Reflux Disease Therapeutics Market Overview

    9.2. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Gastroesophageal Reflux Disease Therapeutics Market

    10.1. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Gastroesophageal Reflux Disease Therapeutics Market

    11.1. Japan Gastroesophageal Reflux Disease Therapeutics Market Overview

    11.2. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Gastroesophageal Reflux Disease Therapeutics Market

    12.1. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Gastroesophageal Reflux Disease Therapeutics Market

    13.1. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Gastroesophageal Reflux Disease Therapeutics Market

    14.1. South Korea Gastroesophageal Reflux Disease Therapeutics Market Overview

    14.2. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Gastroesophageal Reflux Disease Therapeutics Market

    15.1. Western Europe Gastroesophageal Reflux Disease Therapeutics Market Overview

    15.2. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Gastroesophageal Reflux Disease Therapeutics Market

    16.1. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Gastroesophageal Reflux Disease Therapeutics Market

    17.1. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Gastroesophageal Reflux Disease Therapeutics Market

    18.5. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Gastroesophageal Reflux Disease Therapeutics Market

    19.9. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Gastroesophageal Reflux Disease Therapeutics Market

    20.13. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market

    21.1. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market Overview

    21.2. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Gastroesophageal Reflux Disease Therapeutics Market

    22.1. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Gastroesophageal Reflux Disease Therapeutics Market

    23.1. North America Gastroesophageal Reflux Disease Therapeutics Market Overview

    23.2. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Gastroesophageal Reflux Disease Therapeutics Market

    24.1. USA Gastroesophageal Reflux Disease Therapeutics Market Overview

    24.2. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Gastroesophageal Reflux Disease Therapeutics Market

    25.1. Canada Gastroesophageal Reflux Disease Therapeutics Market Overview

    25.2. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Gastroesophageal Reflux Disease Therapeutics Market

    26.1. South America Gastroesophageal Reflux Disease Therapeutics Market Overview

    26.2. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Gastroesophageal Reflux Disease Therapeutics Market

    27.1. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Gastroesophageal Reflux Disease Therapeutics Market

    28.1. Middle East Gastroesophageal Reflux Disease Therapeutics Market Overview

    28.2. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Gastroesophageal Reflux Disease Therapeutics Market

    29.1. Africa Gastroesophageal Reflux Disease Therapeutics Market Overview

    29.2. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Gastroesophageal Reflux Disease Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Gastroesophageal Reflux Disease Therapeutics Market Competitive Landscape

    30.2. Gastroesophageal Reflux Disease Therapeutics Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson and Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novartis AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi S.A.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Gastroesophageal Reflux Disease Therapeutics Market Other Major And Innovative Companies

    31.1. Medtronic PLC

    31.2. GlaxoSmithKline plc

    31.3. Eisai Co. Ltd.

    31.4. Takeda Pharmaceutical Company Limited

    31.5. bioMerieux SA

    31.6. Teva Pharmaceutical Industries

    31.7. Dr. Reddy's Laboratories Ltd.

    31.8. Bruker Corp

    31.9. Amneal Pharmaceuticals LLC

    31.10. CHEPLAPHARM Arzneimittel GmbH

    31.11. Daewoong Pharmaceutical Co. Ltd

    31.12. Ironwood Pharmaceuticals Inc.

    31.13. Sebela Pharmaceuticals Inc.

    31.14. Camber Pharmaceuticals Inc.

    31.15. Sun Pharmaceutical Industries Ltd.

    32. Global Gastroesophageal Reflux Disease Therapeutics Market Competitive Benchmarking

    33. Global Gastroesophageal Reflux Disease Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Gastroesophageal Reflux Disease Therapeutics Market

    35. Gastroesophageal Reflux Disease Therapeutics Market Future Outlook and Potential Analysis

    35.1 Gastroesophageal Reflux Disease Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Gastroesophageal Reflux Disease Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Gastroesophageal Reflux Disease Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson and Johnson Financial Performance
  • Table 77: Novartis AG Financial Performance
  • Table 78: Sanofi S.A. Financial Performance
  • Table 79: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Gastroesophageal Reflux Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Gastroesophageal Reflux Disease Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson and Johnson Financial Performance
  • Figure 77: Novartis AG Financial Performance
  • Figure 78: Sanofi S.A. Financial Performance
  • Figure 79: AstraZeneca plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the gastroesophageal reflux disease therapeutics market?

Gastroesophageal reflux disease (GERD) therapeutics is a medication for chronic medical illness characterized by the upward movement of stomach contents into the esophagus that causes heartburn and regurgitation. The therapeutics are used to neutralize and reduce the production of stomach acid to maintain optimal pH in the gut and prevent the passage of fluids back into the stomach that cause acid reflux. For further insights on the gastroesophageal reflux disease therapeutics market, request a sample here

How will the gastroesophageal reflux disease therapeutics market drivers and restraints affect the gastroesophageal reflux disease therapeutics market dynamics? What forces will shape the gastroesophageal reflux disease therapeutics industry going forward

The gastroesophageal reflux disease therapeutics market major growth driver - Surge In Gastroesophageal Reflux Disease Anticipated To Drive The Growth Of The Gastroesophageal Reflux Disease Therapeutics Market. For further insights on the gastroesophageal request a sample here

What is the forecast market size or the forecast market value of the gastroesophageal reflux disease therapeutics market?

The gastroesophageal reflux disease therapeutics market size has grown steadily in recent years. It will grow from $5.78 billion in 2023 to $6 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to changing lifestyles and dietary habits, aging population, increased awareness and diagnosis, prevailing stressful lifestyles, rise in obesity rates.. The gastroesophageal reflux disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rise in demand for novel therapies, growing geriatric population, personalized medicine approaches, focus on non-pharmacological interventions, emergence of biologics and innovative therapies.. Major trends in the forecast period include alternative therapies and mind-body practices, expanded research into gut health, advent of patient-centric care models, targeted marketing for gerd awareness, integration of digital health tools.. For further insights on the gastroesophageal reflux disease therapeutics market, request a sample here

How is the gastroesophageal reflux disease therapeutics market segmented?

The gastroesophageal reflux disease therapeutics market is segmented
1) By Type: Branded, Generic
2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets
4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative ColitisFor further insights on the gastroesophageal reflux disease therapeutics market,
request a sample here

Which region has the largest share of the gastroesophageal reflux disease therapeutics market? What are the other regions covered in the report?

North America was the largest region in the gastroesophageal reflux disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the gastroesophageal reflux disease therapeutics market, request a sample here.

Who are the major players in the gastroesophageal reflux disease therapeutics market?

Major companies operating in the gastroesophageal reflux disease therapeutics market report are Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca plc, Medtronic PLC, GlaxoSmithKline plc, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, bioMerieux SA, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories Ltd., Bruker Corp, Amneal Pharmaceuticals LLC, CHEPLAPHARM Arzneimittel GmbH, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., EndoGastric Solutions, RaQualia Pharma Inc, TWi Pharmaceuticals Inc., Astellas Pharma Inc., SFJ Pharmaceuticals Group, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Addex Pharmacetuicals. For further insights on the gastroesophageal reflux disease therapeutics market, request a sample here.

What are the key trends in the gastroesophageal reflux disease therapeutics market?

Major trend in the gastroesophageal reflux disease therapeutics market - Innovative Medications To Reshape The Gastroesophageal Reflux Disease Therapeutics Market. For further insights on the gastroesophageal reflux disease therapeutics market, request a sample here.

What are the major opportunities in the gastroesophageal reflux disease therapeutics market? What are the strategies for the gastroesophageal reflux disease therapeutics market?

For detailed insights on the major opportunities and strategies in the gastroesophageal reflux disease therapeutics market, request a sample here.

How does the gastroesophageal reflux disease therapeutics market relate to the overall economy and other similar markets?

For detailed insights on gastroesophageal reflux disease therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the gastroesophageal reflux disease therapeutics industry?

For detailed insights on the mergers and acquisitions in the gastroesophageal reflux disease therapeutics industry, request a sample here.

What are the key dynamics influencing the gastroesophageal reflux disease therapeutics market growth? SWOT analysis of the gastroesophageal reflux disease therapeutics market.

For detailed insights on the key dynamics influencing the gastroesophageal reflux disease therapeutics market growth and SWOT analysis of the gastroesophageal reflux disease therapeutics industry, request a sample here.